Osteitis Deformans
-
Subject Areas on Research
- A clinical approach to diagnosis and management of Paget's disease of bone.
- A single infusion of zoledronic acid produces sustained remissions in Paget disease: data to 6.5 years.
- Antiresorptive effect of a single infusion of microgram quantities of zoledronate in Paget's disease of bone.
- Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone.
- Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease.
- Discussion: Newer bisphosphonates in the treatment of Paget's disease of bone: where we are and where we want to go.
- Factors associated with self-rated health in patients with Paget's disease of bone.
- Functional and mobility impairments associated with Paget's disease of bone.
- Global deletion of Optineurin results in altered type I IFN signaling and abnormal bone remodeling in a model of Paget's disease.
- Heterogeneity in Paget disease of the bone.
- Incidence and natural history of Paget's disease of bone in England and Wales.
- Intraosseous meningioma--a mimicry of Paget's disease?
- Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate.
- Medical management of Paget's disease of bone: indications for treatment and review of current therapies.
- Paget's Disease in Primary Total Hip Arthroplasty Is Associated With Greater In-Hospital Lengths of Stay, Costs, and Complications.
- Paget's Disease of Bone: Osteoimmunology and Osteoclast Pathology.
- Paget's disease of bone and quality of life.
- Paget's disease of bone: an endocrine society clinical practice guideline.
- Peyronie's disease is associated with Paget's disease of bone.
- Response to letter by Ralston et al.
- Response to letter.
- Response to the letter by Asik M., et al.
- Sarcomas arising in Paget disease of bone: a clinicopathologic analysis of 70 cases.
- Severe hypocalcemia following bisphosphonate treatment in a patient with Paget's disease of bone.
- Single infusion of zoledronate in Paget's disease of bone: a placebo-controlled, dose-ranging study.
- VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD.
- What is "resistance" in Paget's disease of bone?
- Zoledronate.